|
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
|
|
Nike Sales Miss in Middle East Region Sparks Investor Concern Bloomberg.comNike shares fall 9% on weak outlook, expected 20% sales decline in China CNBCNike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags WSJNike expects more falling sales, as stock sinks amid worries turnaround is not working MarketWatch
|
|
